Moleculera Biosciences Patient Stories
Mood disorders and OCD triggered by strep infection
At 5 years old, Julie’s son was diagnosed with ADHD, a mood disorder, compulsive behaviors and thoughts, and oppositional disorder. He was prescribed approximately 15 different psychiatric meds over the years.
Watch patients describe how the Autoimmune Brain Panel™
(formerly the Cunningham Panel™) helped changed their lives.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.